Advertising for companies with long, technical sales cycles.
Biond runs Google and LinkedIn campaigns for life science companies, built around how scientific and commercial buyers actually evaluate suppliers and partners.
· WHY GENERIC PPC FALLS SHORT
Why Generic PPC (Pay-Per-Click) Agencies Underperform in Life Science
Most paid advertising agencies are built for B2C or horizontal SaaS. Life science B2B is structurally different. Scientific buyers, including procurement leads, research directors, BD teams, and CRO or CDMO decision makers, recognise surface level messaging quickly. Niche audiences mean keyword volumes are low and targeting has to map to real decision makers, not broad demographic filters.
The metric that matters is whether the right people, at the right stage of evaluation, are entering your pipeline.
· WHAT BIOND OFFERS
Biotech advertising services across Google and LinkedIn
Lead generation campaigns built around scientific buyers
Lead generation campaigns built around scientific buyers, designed to reach the right research, commercial, and procurement stakeholders with messaging aligned to how they evaluate and select solutions.
Bridging scientific evaluation with commercial decision-making.
Google Ads
For buyers actively comparing CROs, CDMOs, tools, instruments, and assay platforms.
LinkedIn Ads
Reach defined roles by title, function, company type, and seniority.
Scientific keyword research
Terms tied to assays, services, and commercial intent, not broad categories.
Audience targeting
Filters that isolate real decision makers from a broad professional network.
Ad copy that holds up
Technically credible, commercially specific, written to survive scrutiny.
Landing page alignment
Pages built around the questions a qualified buyer arrives with.
Measurement tied to pipeline
Reporting framed around qualified leads and meetings, not impressions.
Channel choice depends on what you sell, who you sell to, and where your buyer sits in the decision process.
· HOW IT WORKS
How Biond runs a life science advertising campaign
Audience and keyword research
Map the buyer, the terminology they search with, and the filters that isolate your real audience.
Message and ad copy
Copy that reflects the real problem and holds up to scientific accuracy while earning the click.
Landing page alignment
Pages built around what a qualified buyer needs to see at the point of arrival.
Setup and launch
Disciplined architecture that gives the platform enough signal to optimise without spreading thin.
Measurement tied to pipeline
Reporting on qualified leads and meetings with the right buyers, not vanity metrics.
· WHY IT MATTERS
Scientific understanding changes the quality of the campaign
The difference between a life science advertising agency and a generalist running life science accounts is judgment. When Biond selects keywords for a CDMO campaign, the distinctions between process development, GMP manufacturing, and technology transfer are already understood. That fluency tightens targeting, cuts copy iterations, and makes it clear whether underperformance is a targeting, messaging, or landing page problem, rather than defaulting to bigger budgets.
What an engagement produces
- A documented audience and keyword strategy for each channel
- Ad copy across formats, written for scientific and commercial sophistication
- Campaign architecture in Google Ads and LinkedIn Campaign Manager
- Landing page recommendations aligned to the ad message
- A measurement framework that defines a qualified lead for your business
- Monthly reporting and strategic review tied to pipeline
Who this is for
- Biotech, life science and medtech companies building commercial pipeline
- CROs and CDMOs building inbound interest with pharma and biotech sponsors
- Instrument, genomics, and research service companies with niche buyers
- Companies that ran paid campaigns before without generating qualified leads
- Founders and commercialization leads who need campaigns they can defend internally
· FAQ
Frequently asked questions
What makes biotech advertising different from standard B2B advertising?+
Life science advertising involves niche audiences, long evaluation cycles, and technically literate buyers who scrutinise messaging closely. Keywords that perform well in general B2B, such as broad category terms or feature-focused language, rarely attract qualified buyers in this space. Effective biotech advertising requires keyword and audience strategies built around specific scientific disciplines, applications, and commercial contexts, and ad copy that reflects the way scientific buyers actually evaluate suppliers or partners.
When should a life science company use Google Ads versus LinkedIn Ads? +
Google Ads works well when your buyers are actively searching for a specific service or product category, which is common for CROs, CDMOs, and scientific instrument suppliers. LinkedIn Ads are more effective when you need to reach a defined professional audience by role and organisation, particularly for awareness-building or targeting BD and procurement functions that are not yet in active search mode. Many life science companies benefit from running both channels with different objectives.
How long does it take for a life science advertising campaign to produce results? +
Because life science B2B sales cycles are long, and because niche audiences generate lower click volumes than consumer or horizontal SaaS markets, meaningful pipeline data typically takes longer to accumulate than in other sectors. Most campaigns need at least two to three months before it is possible to draw reliable conclusions about what is working. Biond sets expectations around this from the start and structures measurement accordingly.
Can Biond run advertising for a company that does not yet have clear positioning or messaging?+
Running effective ads without clear positioning is difficult. Ad copy has to say something specific and credible to a targeted audience. If your core value proposition or audience segmentation is not yet defined, Biond recommends addressing that first, either through a positioning and messaging engagement or as part of a broader biotech marketing strategy workstream, before committing budget to paid media.
Do you work with companies outside Singapore?+
Yes. Biond works with life science companies in Singapore, Southeast Asia, and Europe. Most advertising engagements can be managed remotely. For companies based in Singapore, in-person conversations are also an option.
Talk to Biond about your life science advertising
If your campaigns are not generating qualified conversations, or you are planning a first campaign built on a real understanding of your audience and their evaluation process, a short discovery call is a practical starting point.